Àâòîðèçàöèÿ
Ïîèñê ïî óêàçàòåëÿì
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction
Îáñóäèòå êíèãó íà íàó÷íîì ôîðóìå
Íàøëè îïå÷àòêó? Âûäåëèòå åå ìûøêîé è íàæìèòå Ctrl+Enter
Íàçâàíèå: Signal Transduction
Àâòîðû: Gomperts B.D., Tatham P.E.R., Kramer I.M.
Àííîòàöèÿ: Signal Transduction is a text reference on cellular signalling processes. Starting with the basics, it explains how cells respond to external cues (hormones, cytokines, neurotransmitters, adhesion molecules, extracellular matrix, etc), and shows how these inputs are integrated and co-ordinated. The first half of the book provides the conceptual framework, explaining the formation and action of second messengers, particulary cyclic nucleotides and calcium, and the mediation of signal pathways by GTP-binding proteins. The remaining chapters deal with the formation of complex signalling cascades employed by cytokines and adhesion molecules, starting at the membrane and ending in the nucleus, there to regulate gene transcription. In this context, growth is an important potential outcome and this has relevance to the cellular transformations that underlie cancer. The book ends with a description at the molecular level of how signalling proteins interact with their environment and with each other through their structural domains. Each main topic is introduced with a historical essay, detailing the sources key observations and experiments that set the scence for recent and current work.
ßçûê:
Ðóáðèêà: Òåõíîëîãèÿ /
Ñòàòóñ ïðåäìåòíîãî óêàçàòåëÿ: Ãîòîâ óêàçàòåëü ñ íîìåðàìè ñòðàíèö
ed2k: ed2k stats
Ãîä èçäàíèÿ: 2002
Êîëè÷åñòâî ñòðàíèö: 424
Äîáàâëåíà â êàòàëîã: 21.12.2005
Îïåðàöèè: Ïîëîæèòü íà ïîëêó |
Ñêîïèðîâàòü ññûëêó äëÿ ôîðóìà | Ñêîïèðîâàòü ID
Ïðåäìåòíûé óêàçàòåëü
Cell cycle, adhesion molecules in regulation 328—330 330 331
Cell cycle, checkpoints 233 234 240 244
Cell cycle, cyclins expression 234—240 234
Cell cycle, phases 233 233 234—240
Cell cycle, transition points 234
Cell transformation see “Transformation”
Ceramide 162 205
CFTR (cystic fibrosis transmembrane conductance regulator) 112
CGD (chronic granulomatous disease) 214 217
Checkpoint protein-kinase-1 see “Chk-1”
Checkpoint protein-kinase-2 see “Chk-2”
Chelating agents 148
Chemokine receptors 352 353
Chemokines 23 320 347 349 351—354 351
Chemotaxis 347
Chk-1 (checkpoint protein-kinase-1) 243
Chk-2 (checkpoint protein-kinase-2) 243
Chlorpromazine 48
Cholecystokinin 19 20
Cholera toxin 116—119
Cholinergic receptors 38—42
Chromatid segregation 238 239 240 244—245
Chronic granulomatous disease see “CGD”
CICR ( -induced release) 155 167 182
Clonidine 36 37 62
Cohesin 244 245
Conductin 333
cones 130
Contact inhibition 334
CRE (cyclic AMP response element) 194
CREB (cyclic AMP response element binding protein) 194—195 194
CREB binding protein see “CBP”
CrkL 263
Csk (C-terminal Src kinase) 295 409
CTP (cytidine triphosphate) 71
Cullin see “Cdc53”
Curare 15 16
CXC chemokines 351 357 352
Cyclic ADP-ribose see “cADPr”
Cyclic AMP 25 62 107—109
Cyclic AMP response element see “CRE”
Cyclic AMP response element binding protein see “CRB”
Cyclic AMP, signalling convergence 176
Cyclic AMP, 7TM receptor signalling 54 55
Cyclic AMP, cellular response estimation 27 29
Cyclic AMP, formation from ATP 109 109 110
Cyclic AMP, historical aspects 31—32 107
Cyclic AMP, ion channel regulation 197
Cyclic AMP, phosphorylation-related signal amplification 191—192
Cyclic AMP, PKA activation 192—193 193
Cyclic AMP, suppression by adrenergic antagonists 36
Cyclic AMP, theophylline actions 30 31
Cyclic AMP-dependent protein kinase see “PKA”
Cyclic GMP visual transduction 127 133—135
Cyclic GMP-dependent kinase see “G kinase”
Cyclin A 235 236 237
Cyclin B 237 238 240 243
Cyclin D 211 235 236 236 240 241 330
Cyclin E 211 235 236 241 246 330
Cyclin H 235
Cyclin-dependent protein kinases see “CDKs”
Cyclins 234 234
Cyclins, cell cycle expression 234—240 234
Cyclins, cell cycle expression, G1 phase 235—236 235 236
Cyclins, cell cycle expression, G2 phase 237—238 237
Cyclins, cell cycle expression, mitosis 238—240
Cyclins, cell cycle expression, S phase 236—237
Cyclophilin 388 390
Cyclosporin 190 388 390
Cystic fibrosis transmembrane conductance regulator see “CFTR”
Cytidine triphosphate see “CTP”
Cytochrome c, apoptosis regulation 339—340 340
Cytokines 22—23 232
Cytokines, inflammatory mediators 213 345
Cytokines, signalling pathways 291
Cytoskeleton 180
Cytoskeleton, adhesion molecule linkage 317 319 325 328 331
Cytoskeleton, rearrangement at mitosis 238
Cytotoxic T lymphocytes 284 285 317
D-Ras 86
daf 1 to daf 4 361 365 365
DAG (diacylglycerol) 25 115 120 179 261 265 285
DAG kinase 179
DAG, PKC activation 198 199 201 203 203 215
DAG, PKC activation, sources 204—205 204
Dephosphorylation 189 190 373—383 374
Dephosphorylation, CREB 195—196
Dephosphorylation, negative regulation 379—383
Desensitization, homologous/heterologous of phosphorylated receptors 85
Desensitization, nicotinic receptors 49—50
Desensitization, proteinase activated receptors (PARs) 58
Desmoplakin 331
Desmosomes 322 322 331—332
DFP (diisopropyl fluorophosphate) 49
DHPR 159 165 166 182
Diacylglycerol see “DAG”
Differentiation 22
Differentiation, role of adherent junctions 332
Dihydrofolate reductase 237
Dihydropyridines 157
Diisopropyl fluorophosphate see “DFP”
Dissociation constant (KD) 26 27 31
DNA helicase 237
DNA polymerase 237
DNA repair 243—244
DNA-PK (DNA-dependent protein kinase) 337
Dopamine 33 34
Dopamine receptors 61
Downstream of receptor kinases see “Drk”
DP-1 235
dpp 359 364 365
Drk (downstream of receptor kinases) 267—268
Drosophila, receptor homologues 361 364—365
Drosophila, MAP kinases 275
Drosophila, photoreceptor development 266—268 267 268
Drosophila, phototransduction 141 142 158 206—208 207
Drosophila, Ras proteins 86
Drosophila, Smad homologues 366 368
Drosophila, tyrosine phosphatases 377 378
E-selectin 323 351 354
E2F 235 236 242
E6 protein 243
EC50 27—28 29 30 31
EF-2 kinase (elongation factor-2 kinase) 275
EF-hand motifs 171 173 174 177 179 180 183 401—402 402
EGF (epidermal growth factor) 20
EGF receptor 4 229 249
EGF receptor, activation 259 261 265 271
EGF, historical aspects 227—230 229
EGTA 148 148 181
Eicosanoids 23
Eicosanoids, receptor binding 55
EILDV motifs 318
ELAM-1 318
Electric organs 42—43
eLF-4E 272 273 307—308
Elongation factor-2 kinase see “EF-2 kinase”
Endocytosis 31 84
Endoglin 362
Endonexin fold 172
Endorphins 3
Endothelial cell adhesion molecules 349—351
Epac 197—198 198
Ephedrine 2 37
Epidermal growth factor see “EGF”
Epidermolysis bullosa 332
Epinephrine see “Adrenaline”
EPO (erythropoietin) 284
Epo receptor 284 380—381
Equilibrium constant 26
Erb-B 229 230 249
Ergot 11 12—14
Ergotamine 14
ERK (extracellular signal regulated protein kinase) 80 84 92 210 270 271 274 330
ERK, activation 196—197 196 271 407
ERK, activation, 7TM receptors 276—279
ERK, protein synthesis regulation 272—273 273
ERK, transcription activation 271—272 272
ERK1 274
ERK2 274
Erythropoietin see “Epo”
Eserine 14
Excitation-contraction coupling 157 182
Exocytosis 157 179 181
Exocytosis, signalling pathways 289
Extracellular matrix 315 317 319 324
Extracellular signal regulated protein kinase see “ERK”
F-actin 180
F-box 246
Fab fragments 316
FADD 339 350
FAK (focal adhesion kinase) 325 326 329 337
Fas 339
Fas ligand 339 339
FGF (fibroblast growth factor) 249
Fibrinogen 319
Fibroblast growth factor see “FGF”
Fibronectin 317 325 328
FK506 154 188
FKBP 388
FKBP12 154 155 361 369
FKHRL 326
Flash 339
fMLP (formyl-Met-Leu-Phe) 354
Focal adhesion complexes 235 328—329 329
Focal adhesion kinase see “FAK”
Follicle stimulating hormone see “FSH”
Forskolin 117
Forskolin, adenylyl cyclase activation 109 112 116
Fos 208 209 271 272 276
FRAP/mTOR 308
FSH (follicle stimulating hormone) 20 22 195
Fura2 151 152
fyn 286 294 329
G kinase (cyclic GMP-dependent kinase) 178
G-proteins 42 72
G-proteins, -binding 149
G-proteins, activation 123—124
G-proteins, -subunits 72 77 95—96 109
G-proteins, -subunits, -subunit interactions 80 84 109
G-proteins, -subunits, adenylyl cyclase interaction 80 96 109 110 112 113
G-proteins, -subunits, diversity 79—80 79
G-proteins, -subunits, expression patterns 80
G-proteins, -subunits, functions 78 80
G-proteins, -subunits, sites interacting with membranes/proteins 80—82
G-proteins, -subunits, structural studies 81—82 81
G-proteins, -subunits 72 82—85 95—96
G-proteins, -subunits, functions 84
G-proteins, -subunits, negative feedback signals 84—85
G-proteins, -subunits, signal transmission 83—84
G-proteins, 7TM receptor linkage 72 73 99
G-proteins, activation without subunit dissociation 95—100
G-proteins, GTPase cycle 74—75 74
G-proteins, heterotrimeric 73—74 73
G-proteins, heterotrimeric, post-translational modifications 82 82 83
G-proteins, monomeric 73
G-proteins, monomeric, oncogene products 85—86
G-proteins, phototransduction 130 131
G-proteins, receptor affinity modulation 76 77
G0 phase 234
G1 phase 233 233 234 235—236 235 236
G2 phase 233 233 237—238 237
G2 phase, checkpoint 243 244
GABA ( -aminobutyric acid) 24
GABA receptors 42 50 56
GABAA receptors 42
GABAB receptors 42 51
GABAB receptors, heterodimers 61
GABAC receptors 42
GAG 86
Gap junctions 165
GAP-43 200
Gastrin 19 20
GCAP (guanylyl cyclase activating protein) 136
GEFs (guanine nucleotide exchange factors) 95 197
Gelsolin 180 337
Geranylgeranyl groups, G-protein subunit post-translational modification 82 83
GH (growth hormone) see “Somatotropin”
Glucagon 20 62
Glucagon, receptor binding 55
Gluconeogenesis 71
Glucose transport 307
GLUT4 307
Glutamate 19 24 133
Glutamate receptors 42 56
Glutamate receptors, iGlu 4 42
Glutamate receptors, ion channel linkage 50—51 158
Glutamate receptors, mGlu 42 51
Glutamate receptors, mGlu, homodimers 62
Glycine 24
Glycine receptors 50
Glycogen metabolism, PP1 regulation 386—388 386 387
Glycogen phosphorylase 191 191
Glycogen synthase 175 307 308 386 387
Glycogen synthase kinase see “GSK”
Glycogen synthesis 107—108 108 306 307
Glycogenolysis 107 108 175 176 191—192 191 386 387
Glycogenolytic hormones 299
Glycosaminoglycans 324
GM-CSF (granulocyte-monocyte colony stimulating factor) 23 349
GM1 118 119
GnRH (gonadotrophin-releasing hormone) 3
Granulocyte-monocyte colony-stimulating factor see “GM-CSF”
Grb2 (growth factor receptor binding protein-2) 269 277 287 329
Growth factors 22 225—251
Growth factors, multiple effects 19 22
Growth factors, nomenclature 232
Growth hormone (GH) see “Somatotropin”
GSK (glycogen synthase kinase) 175 209
GSK- 307 333
GTP 71 72
GTP, stable analogues 76 76
GTP-binding proteins 2 71—100
GTP-binding proteins, 7TM receptor signalling 54
GTP-binding proteins, subunits 72
GTP-binding proteins, terminology 72—73
GTPase 72 90—91
GTPase activating G-protein see “IRA”
GTPase, activation mechanisms 93—95 94
GTPase, GTP/GDP cycle 74—75 74
GTPase, regulation 75—76
Guanine nucleotide exchange factors see “GEFs”
Guanylyl cyclase activating protein see “GCAP”
H-Ras, Ha-Ras 86 211
Haemopoetic growth factor receptors 381
Haloperidol 61
Helper T lymphocytes 284 285 288
Hepatocyte growth factor 328
Heterologous desensitization 85 85
Histamine 20 23 212
Histamine, receptor binding 55
Histones 237 238
HIV (human immunodeficiency virus) 352
Homologous desensitization 85 85
Hormones 2 19 20 21
Hormones, cellular response measurement (EC50) 27 29
Hormones, definition 9
Hormones, historical background 4—8
Hormones, lipophilic 24—25
Hormones, multiple effects 19
Ðåêëàìà